Seroflo 250 synchrobreathe Inhaler (Salmeterol/Fluticasone) in United states of America , United Kingdom ,France , Australia

Seroflo 250 Synchrobreathe Inhaler (Salmeterol / Fluticasone)

Seroflo 250 Synchrobreathe Inhaler (Salmeterol / Fluticasone) is a combination inhaler used for the long-term treatment and control of asthma and chronic obstructive pulmonary disease (COPD). It contains Salmeterol, a long-acting bronchodilator that relaxes the airway muscles, and Fluticasone, a corticosteroid that helps reduce inflammation and swelling in the airways.

This dual-action inhaler helps improve breathing by keeping the airways open and reducing airway inflammation, preventing symptoms such as wheezing, coughing, chest tightness, and shortness of breath. The Synchrobreathe inhaler device ensures efficient delivery of medication directly into the lungs for better respiratory control.

TabExports supplies Seroflo 250 Synchrobreathe Inhaler (Salmeterol / Fluticasone) to international pharmaceutical markets with reliable export services and consistent product quality

Key Benefits

• Helps manage asthma and COPD symptoms

• Reduces airway inflammation

• Improves airflow to the lungs

• Helps prevent wheezing and breathing difficulties

• Provides long-lasting respiratory control

Uses

• Asthma management

• Chronic obstructive pulmonary disease (COPD)

• Prevention of bronchospasm

• Long-term respiratory therapy

Active Ingredients

• Salmeterol

• Fluticasone

Global Supply by TabExports

TabExports exports Seroflo 250 Synchrobreathe Inhaler (Salmeterol / Fluticasone) to international markets including the United States of America, the United Kingdom, France, Australia, and Thailand. We ensure high-quality pharmaceutical products with secure packaging and reliable global delivery.

Storage Instructions

Store in a cool and dry place away from direct sunlight. Keep the inhaler in its original packaging and out of reach of children.

Disclaimer

Use this medication only as prescribed by a healthcare professional. Do not exceed the recommended dosage without medical advice.